These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 2544997)

  • 1. Human diabetes associated with a deletion of the tyrosine kinase domain of the insulin receptor.
    Taira M; Taira M; Hashimoto N; Shimada F; Suzuki Y; Kanatsuka A; Nakamura F; Ebina Y; Tatibana M; Makino H
    Science; 1989 Jul; 245(4913):63-6. PubMed ID: 2544997
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Insulin resistance and diabetes due to different mutations in the tyrosine kinase domain of both insulin receptor gene alleles.
    Kusari J; Takata Y; Hatada E; Freidenberg G; Kolterman O; Olefsky JM
    J Biol Chem; 1991 Mar; 266(8):5260-7. PubMed ID: 2002058
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A mutation (Trp1193-->Leu1193) in the tyrosine kinase domain of the insulin receptor associated with type A syndrome of insulin resistance.
    Iwanishi M; Haruta T; Takata Y; Ishibashi O; Sasaoka T; Egawa K; Imamura T; Naitou K; Itazu T; Kobayashi M
    Diabetologia; 1993 May; 36(5):414-22. PubMed ID: 8390949
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A naturally occurring mutation of insulin receptor alanine 1134 impairs tyrosine kinase function and is associated with dominantly inherited insulin resistance.
    Moller DE; Yokota A; White MF; Pazianos AG; Flier JS
    J Biol Chem; 1990 Sep; 265(25):14979-85. PubMed ID: 2168397
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A glycine-1008 to valine mutation in the insulin receptor in a woman with type A insulin resistance.
    Nozaki O; Suzuki Y; Shimada F; Hashimoto N; Taira M; Hatanaka Y; Notoya Y; Kanashiro O; Makino H; Yoshida S
    J Clin Endocrinol Metab; 1993 Jul; 77(1):169-72. PubMed ID: 8392082
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Defect in tyrosine kinase activity of the insulin receptor from a patient with insulin resistance and acanthosis nigricans.
    Yamamoto R; Shiba T; Tobe K; Shibasaki Y; Koshio O; Izumi T; Odawara M; Mikami Y; Matsuura N; Akanuma Y
    J Clin Endocrinol Metab; 1990 Apr; 70(4):869-78. PubMed ID: 2180980
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human diabetes associated with a mutation in the tyrosine kinase domain of the insulin receptor.
    Odawara M; Kadowaki T; Yamamoto R; Shibasaki Y; Tobe K; Accili D; Bevins C; Mikami Y; Matsuura N; Akanuma Y
    Science; 1989 Jul; 245(4913):66-8. PubMed ID: 2544998
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alternative splicing of exon 17 and a missense mutation in exon 20 of the insulin receptor gene in two brothers with a novel syndrome of insulin resistance (congenital fiber-type disproportion myopathy).
    Vorwerk P; Christoffersen CT; Müller J; Vestergaard H; Pedersen O; De Meyts P
    Horm Res; 1999; 52(5):211-20. PubMed ID: 10844410
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NIDDM associated with mutation in tyrosine kinase domain of insulin receptor gene.
    Cocozza S; Porcellini A; Riccardi G; Monticelli A; Condorelli G; Ferrara A; Pianese L; Miele C; Capaldo B; Beguinot F
    Diabetes; 1992 Apr; 41(4):521-6. PubMed ID: 1607076
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insulin receptor tyrosine kinase activity is abnormal in circulating cells and cultured fibroblasts but normal in transformed lymphocytes from a type A insulin-resistant patient.
    Grunberger G; Comi RJ; Carpentier JL; Podskalny JM; McElduff A; Taylor SI; Gorden P
    J Lab Clin Med; 1988 Jul; 112(1):122-32. PubMed ID: 3292678
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Type C insulin resistance].
    Hashimoto N; Makino H
    Nihon Rinsho; 1994 Oct; 52(10):2637-40. PubMed ID: 7983790
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insulin-resistant diabetes associated with partial deletion of insulin-receptor gene.
    Shimada F; Taira M; Suzuki Y; Hashimoto N; Nozaki O; Taira M; Tatibana M; Ebina Y; Tawata M; Onaya T
    Lancet; 1990 May; 335(8699):1179-81. PubMed ID: 1971035
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A 3-basepair in-frame deletion (delta Leu999) in exon 17 of the insulin receptor gene in a family with insulin resistance.
    Awata T; Matsumoto C; Momomura K; Takahashi Y; Odawara M; Kasuga M; Kadowaki T; Iwamoto Y
    J Clin Endocrinol Metab; 1994 Dec; 79(6):1840-4. PubMed ID: 7989492
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insulin resistance associated with substitution of histidine for arginine 252 in the alpha-subunit of the human insulin receptor: trial of insulin-like growth factor I injection therapy to enhance insulin sensitivity.
    Nakashima N; Umeda F; Yanase T; Nawata H
    J Clin Endocrinol Metab; 1995 Dec; 80(12):3662-7. PubMed ID: 8530617
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ala1048-->Asp mutation in the kinase domain of insulin receptor causes defective kinase activity and insulin resistance.
    Haruta T; Takata Y; Iwanishi M; Maegawa H; Imamura T; Egawa K; Itazu T; Kobayashi M
    Diabetes; 1993 Dec; 42(12):1837-44. PubMed ID: 8243830
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Abnormal messenger ribonucleic acid (mRNA) transcribed from a mutant insulin receptor gene in a patient with type A insulin resistance.
    Shimada F; Suzuki Y; Taira M; Hashimoto N; Nozaki O; Makino H; Yoshida S
    Diabetologia; 1992 Jul; 35(7):639-44. PubMed ID: 1644241
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Defect in insulin receptor phosphorylation in erythrocytes and fibroblasts associated with severe insulin resistance.
    Grigorescu F; Flier JS; Kahn CR
    J Biol Chem; 1984 Dec; 259(24):15003-6. PubMed ID: 6392291
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Two patients with insulin resistance due to decreased levels of insulin-receptor mRNA.
    Imano E; Kadowaki H; Kadowaki T; Iwama N; Watarai T; Kawamori R; Kamada T; Taylor SI
    Diabetes; 1991 May; 40(5):548-57. PubMed ID: 1673662
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Substitution of Leu for Pro-193 in the insulin receptor in a patient with a genetic form of severe insulin resistance.
    Carrera P; Cordera R; Ferrari M; Cremonesi L; Taramelli R; Andraghetti G; Carducci C; Dozio N; Pozza G; Taylor SI
    Hum Mol Genet; 1993 Sep; 2(9):1437-41. PubMed ID: 8242067
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Substitution of glutamic acid for alanine 1135 in the putative "catalytic loop" of the tyrosine kinase domain of the human insulin receptor. A mutation that impairs proteolytic processing into subunits and inhibits receptor tyrosine kinase activity.
    Cama A; de la Luz Sierra M; Quon MJ; Ottini L; Gorden P; Taylor SI
    J Biol Chem; 1993 Apr; 268(11):8060-9. PubMed ID: 8096518
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.